Michelle Liu

Michelle Liu is a seasoned professional with extensive experience in commercial strategy and planning within the pharmaceutical and biotechnology sectors. Currently serving as Senior Director of Commercial Strategy and Planning at Exelixis since May 2022, Michelle previously held leadership positions at Aimmune Therapeutics and Jazz Pharmaceuticals, where responsibilities included new product planning and global commercial development. Michelle's career also features roles at Dermira, Health IQ, and Sugna Ventures, along with earlier positions at Mentor Worldwide and The Janssen Pharmaceutical Companies. Michelle holds an MBA/MPH in Business and Public Health from the University of California, Berkeley, and a Bachelor of Arts in Chemistry from Wellesley College.